Altered circadian genes expression in breast cancer tissue according to the clinical characteristics
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AffiliationNofer Institute of Occupational Medicine
MetadataShow full item record
AbstractBreast cancer has a multifactorial etiology. One of the supposed and novel mechanisms is an alteration of circadian gene expression. Circadian genes play a crucial role in many physiological processes. These processes, such as genomic stability, DNA repair mechanism and apoptosis, are frequently disrupted in breast tumors. To assess the significance of circadian gene expression in breast cancer, we carried out an analysis of CLOCK, BMAL1, NPAS2, PER1, PER2, PER3 and CRY1, CRY2, TIMELESS, CSNK1E expression by the use of the quantitative Real-Time PCR technique in tumor tissue and non-tumor adjacent normal tissue sampled from 107 women with a newly diagnosed disease. The obtained data were compared to the clinical and histopathological features. PER1, PER2, PER3, CRY2 were found to be significantly down-expressed, while CLOCK, TIMELESS were over-expressed in the studied tumor samples compared to the non-tumor samples. Only gene expression of CRY1 was significantly down-regulated with progression according to the TNM classification. We found significantly decreased expression of CRY2, PER1, PER2 genes in the ER/PR negative breast tumors compared to the ER/PR positive tumors. Additionally, expression of CRY2, NPAS2 genes had a decreased level in the poorly differentiated tumors in comparison with the well and moderately differentiated ones. Our results indicate that circadian gene expression is altered in breast cancer tissue, which confirms previous observations from various animal and in vitro studies.
CitationPLoS ONE 2018, 13 (6):e0199622
SponsorsThis work was supported by the National Science Center (Grant No. 2014/15/N/NZ5/01671) (to ML), https://www.ncn.gov.pl/?language=en, and partially supported by Ministry of Science and Higher Education Poland DIR/WK/2017/01 (to LK), http://www.nauka.gov.pl/en/, and Internal grant for statutory activity at Nofer Institute of Occupational Medicine IMP 14.4/2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The following license files are associated with this item:
- Differential patterns in the periodicity and dynamics of clock gene expression in mouse liver and stomach.
- Authors: Mazzoccoli G, Francavilla M, Pazienza V, Benegiamo G, Piepoli A, Vinciguerra M, Giuliani F, Yamamoto T, Takumi T
- Issue date: 2012 Dec
- Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
- Authors: Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R, Schmidt M, Rahnenführer J, Oster H, Hengstler JG
- Issue date: 2014
- Circadian gene expression and clinicopathologic correlates in pancreatic cancer.
- Authors: Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA
- Issue date: 2013 Mar
- Expression of circadian core clock genes in fibroblasts of human gingiva and periodontal ligament is modulated by L-Mimosine and hypoxia in monolayer and spheroid cultures.
- Authors: Janjić K, Kurzmann C, Moritz A, Agis H
- Issue date: 2017 Jul
- Altered expression of circadian clock genes in head and neck squamous cell carcinoma.
- Authors: Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY
- Issue date: 2012 Feb